Related Experiment Videos
[Chronic active hepatitis and possible relationship with immunosuppressive therapy].
V B de Carvalho1, F A Fonseca, A de Oliveira e Silva
1Hospital São Joaquim da Real e Benemérita, Sociedade Portuguesa de Beneficência de São Paulo, Capital.
Arquivos Brasileiros De Cardiologia
|July 1, 1991
Summary
A heart transplant recipient developed chronic active hepatitis, likely due to immunosuppressive drugs like azathioprine and cyclosporine. Adjusting medication dosages improved liver function, though the exact cause remained unclear.
Area of Science:
- Hepatology
- Transplant Medicine
- Immunology
Background:
- Chagas cardiomyopathy necessitates heart transplantation.
- Post-transplant complications can include liver dysfunction.
- Immunosuppressive therapy is crucial after organ transplantation.
Observation:
- A 54-year-old male heart transplant recipient developed elevated liver enzymes five months post-surgery.
- Histopathology confirmed chronic active hepatitis.
- The patient was on azathioprine and cyclosporine-A for immunosuppression.
Findings:
- Transitory interruption and dose reduction of azathioprine, along with lower cyclosporine-A doses, led to clinical and laboratory improvement.
- The precise etiology of the hepatitis was undetermined.
- Drug-induced liver injury was suspected, but viral causes could not be excluded.
Implications:
- Careful monitoring of liver function in transplant recipients on immunosuppressants is essential.
- Immunosuppressive drug regimens may require adjustment to manage hepatotoxicity.
- Further research is needed to elucidate the pathogenesis of post-transplant hepatitis in Chagas patients.